🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Express Worries

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of unknown origin.

Some professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Removal

Based on the social media company, the service has removed violative material and banned related keywords and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

Within minutes of entering one community, a vendor shared contact information, where most purchases occur. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Product Details and Pricing

Within these groups, posts display black plastic parcels with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly significant medical dangers”.